These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 10470184

  • 1. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.
    Gebauer G, Rieger M, Jäger W, Lang N.
    Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184
    [Abstract] [Full Text] [Related]

  • 2. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P, Facchini V.
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [Abstract] [Full Text] [Related]

  • 3. IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors.
    Gebauer G, Rieger M, Jäger W, Lang N.
    Anticancer Res; 1999 Mar; 19(4A):2535-6. PubMed ID: 10470190
    [Abstract] [Full Text] [Related]

  • 4. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P, Frydecka I, Gabryś M, Van Dalen A, Einarsson R, Harłozińska A.
    Cancer; 2002 Nov 01; 95(9):1886-93. PubMed ID: 12404282
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Nov 01; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.
    Rinsho Ketsueki; 1999 Aug 01; 40(8):639-45. PubMed ID: 10496038
    [Abstract] [Full Text] [Related]

  • 7. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD, Garcia-Vázquez MD, López-Michelena T, Gardeazabal J, Bilbao J, Cañavate ML, Galdeano AG, Izu R, Díaz-Ramón L, Raton JA, Díaz-Pérez JL.
    Br J Cancer; 2000 Oct 01; 83(7):847-52. PubMed ID: 10970683
    [Abstract] [Full Text] [Related]

  • 8. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
    Siemińska A.
    Pol Merkur Lekarski; 2004 Feb 01; 16(92):188-90. PubMed ID: 15176308
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B, Psenko V, Lipsey AL, Kaiser HE.
    Anticancer Res; 1996 Feb 01; 16(1):219-24. PubMed ID: 8615612
    [Abstract] [Full Text] [Related]

  • 13. Soluble immunological parameters and early prognosis of renal cell cancer patients.
    Kallio JP, Tammela TL, Marttinen AT, Kellokumpu-Lehtinen PL.
    J Exp Clin Cancer Res; 2001 Dec 01; 20(4):523-8. PubMed ID: 11876546
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.
    Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC, Mills GB.
    Cancer; 1995 Nov 01; 76(9):1615-20. PubMed ID: 8635066
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
    van Dalen A, Favier J, Baumgartner L, Hasholzner U, de Bruijn H, Dobbler D, Dombi VH, Fink D, Giai M, McGing P, Harlozinska A, Kainz C, Markowska J, Molina R, Sturgeon C, Einarsson R.
    Anticancer Res; 1999 Nov 01; 19(4A):2523-6. PubMed ID: 10470187
    [Abstract] [Full Text] [Related]

  • 20. The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract.
    Gottschlich S, Görögh T, Lippert BM, Niemann AM, Folz BJ, Werner JA.
    Anticancer Res; 1997 Nov 01; 17(4B):2921-2. PubMed ID: 9329564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.